Prognostic significance of urokinase-type plasminogen activator and plasminogen activator inhibitor-I in primary breast cancer
1998

Prognostic Significance of Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Breast Cancer

Sample size: 429 publication Evidence: moderate

Author Information

Author(s): A Knoop, PA Andreasen, JA Andersen, S Hansen, A-V Laenkholm, ACW Simonsen, J Andersen, J Overgaard, C Rose

Primary Institution: Odense University Hospital

Hypothesis

The study investigates the relationship between uPA and PAI-1 levels in breast cancer and their correlation with prognosis.

Conclusion

High levels of PAI-1 are associated with an increased risk of distant metastasis in breast cancer patients.

Supporting Evidence

  • Patients with high levels of uPA or PAI-1 had an increased risk of relapse and death.
  • PAI-1 was found to independently predict distant metastasis.
  • Neither uPA nor PAI-1 provided information regarding local recurrence.

Takeaway

This study found that higher levels of certain proteins in breast cancer tumors can help predict if a patient might have a relapse or die from the disease.

Methodology

The study analyzed tumor extracts from 429 breast cancer patients using an enzyme-linked immunosorbent assay to measure uPA and PAI-1 levels.

Limitations

The study is retrospective and may not account for all confounding factors.

Participant Demographics

The study included 429 primary breast cancer patients with a median follow-up of 5.1 years.

Statistical Information

P-Value

p<0.0001

Confidence Interval

1.22-2.46

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication